These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 27875358)

  • 1. "Mesalazine in the Treatment of Symptomatic Uncomplicated Diverticular Disease: Reply".
    Tursi A
    J Clin Gastroenterol; 2019 Mar; 53(3):e130-e132. PubMed ID: 27875358
    [No Abstract]   [Full Text] [Related]  

  • 2. Mesalazine in the Treatment of Symptomatic Uncomplicated Diverticular Disease.
    Dai C; Jiang M; Sun MJ
    J Clin Gastroenterol; 2019 Jan; 53(1):77-78. PubMed ID: 27898520
    [No Abstract]   [Full Text] [Related]  

  • 3. Mesalazine for People with Diverticular Disease: A Systematic Review of Randomized Controlled Trials.
    Iannone A; Ruospo M; Wong G; Barone M; Principi M; Di Leo A; Strippoli GFM
    Can J Gastroenterol Hepatol; 2018; 2018():5437135. PubMed ID: 30320044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesalazine for the Treatment of Symptomatic Uncomplicated Diverticular Disease of the Colon and for Primary Prevention of Diverticulitis: A Systematic Review of Randomized Clinical Trials.
    Picchio M; Elisei W; Brandimarte G; Di Mario F; Malfertheiner P; Scarpignato C; Tursi A
    J Clin Gastroenterol; 2016 Oct; 50 Suppl 1():S64-9. PubMed ID: 27622370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesalazine to treat symptomatic uncomplicated diverticular disease and to prevent acute diverticulitis occurrence. A systematic review with meta-analysis of randomized, placebo-controlled trials.
    Picchio M; Elisei W; Tursi A
    J Gastrointestin Liver Dis; 2018 Sep; 27(3):291-297. PubMed ID: 30240473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review article: the pathophysiology and medical management of diverticulosis and diverticular disease of the colon.
    Tursi A; Papa A; Danese S
    Aliment Pharmacol Ther; 2015 Sep; 42(6):664-84. PubMed ID: 26202723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of mesalazine on recurrence of diverticulitis in patients with symptomatic uncomplicated diverticular disease: a meta-analysis with trial sequential analysis of randomized controlled trials.
    Khan RMA; Ali B; Hajibandeh S; Hajibandeh S
    Colorectal Dis; 2018 Jun; 20(6):469-478. PubMed ID: 29520987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rifaximin plus mesalazine followed by mesalazine alone is highly effective in obtaining remission of symptomatic uncomplicated diverticular disease.
    Brandimarte G; Tursi A
    Med Sci Monit; 2004 May; 10(5):PI70-3. PubMed ID: 15114281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of mesalazine in diverticular disease.
    Di Mario F; Comparato G; Fanigliulo L; Aragona G; Cavallaro LG; Cavestro GM; Franzé A
    J Clin Gastroenterol; 2006 Aug; 40 Suppl 3():S155-9. PubMed ID: 16885700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of Diverticular Disease With Aminosalicylates: The Evidence.
    Barbara G; Cremon C; Barbaro MR; Bellacosa L; Stanghellini V
    J Clin Gastroenterol; 2016 Oct; 50 Suppl 1():S60-3. PubMed ID: 27622369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aminosalicylates.
    Gross V
    Dig Dis; 2012; 30(1):92-9. PubMed ID: 22572694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rationale and evidences for treatment of symptomatic uncomplicated diverticular disease.
    Cuomo R; Cargiolli M; Andreozzi P; Zito FP; Sarnelli G
    Minerva Gastroenterol Dietol; 2017 Jun; 63(2):130-142. PubMed ID: 27973463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesalazine for diverticular disease of the colon--a new role for an old drug.
    Tursi A
    Expert Opin Pharmacother; 2005 Jan; 6(1):69-74. PubMed ID: 15709884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of complications and symptomatic recurrences in diverticular disease with mesalazine: a 12-month follow-up.
    Comparato G; Fanigliulo L; Cavallaro LG; Aragona G; Cavestro GM; Iori V; Maino M; Mazzocchi G; Muzzetto P; Colla G; Sianesi M; Franzé A; Mario FD
    Dig Dis Sci; 2007 Nov; 52(11):2934-41. PubMed ID: 17410435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesalazine and rifaximin in symptomatic uncomplicated diverticular disease.
    Festi D; Colecchia A
    Am J Gastroenterol; 2009 Feb; 104(2):532. PubMed ID: 19174809
    [No Abstract]   [Full Text] [Related]  

  • 16. Course of the Diverticular Disease: What is changing?
    Milosavljeviĉ T; Brandimarte G; Stollman N; Barbara G; Lahat A; Scarpignato C; Lanas A; Papa V; Tursi A; Nardone G
    J Gastrointestin Liver Dis; 2019 Dec; 28(suppl. 4):11-16. PubMed ID: 31930229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomised clinical trial: mesalazine and/or probiotics in maintaining remission of symptomatic uncomplicated diverticular disease--a double-blind, randomised, placebo-controlled study.
    Tursi A; Brandimarte G; Elisei W; Picchio M; Forti G; Pianese G; Rodino S; D'Amico T; Sacca N; Portincasa P; Capezzuto E; Lattanzio R; Spadaccini A; Fiorella S; Polimeni F; Polimeni N; Stoppino V; Stoppino G; Giorgetti GM; Aiello F; Danese S
    Aliment Pharmacol Ther; 2013 Oct; 38(7):741-51. PubMed ID: 23957734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of diverticular disease of the colon and prevention of acute diverticulitis: a systematic review.
    Maconi G; Barbara G; Bosetti C; Cuomo R; Annibale B
    Dis Colon Rectum; 2011 Oct; 54(10):1326-38. PubMed ID: 21904150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of diverticular disease, targeting symptoms or underlying mechanisms.
    Cuomo R; Cargiolli M; Cassarano S; Carabotti M; Annibale B
    Curr Opin Pharmacol; 2018 Dec; 43():124-131. PubMed ID: 30291995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesalazine in preventing acute diverticulitis occurrence: a meta-analysis of randomized controlled trials.
    Tursi A; Picchio M
    J Gastrointestin Liver Dis; 2016 Sep; 25(3):409-11. PubMed ID: 27689212
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.